Enterome completes patient enrollment of Phase 2
ROSALIE study evaluating its lead immunotherapy,
EO2401, in recurrent glioblastoma
DOMAIN THERAPEUTICS strengthens Scientific Advisory Board with appointment of immuno-oncology experts
La HealthTech et les hôpitaux se rencontrent au service de la santé de demain
Trois nouveaux administrateurs intègrent le Conseil d’Administration de France Biotech